What is GI Windows?
GI Windows is a medical device company established in 2012 and headquartered in Westwood, Massachusetts. The company specializes in developing innovative anastomoses technology, a critical component in surgical procedures for connecting tubular structures. This focus positions GI Windows at the forefront of advancements in surgical instrumentation, aiming to improve patient outcomes and procedural efficiency. The company's commitment to pioneering solutions in this specialized medical field has attracted significant investment.
How much funding has GI Windows raised?
GI Windows has raised a total of $53.4M across 2 funding rounds:
Series A
$16.4M
Series B
$37M
Series A (2020): $16.4M with participation from JC Investco, Sonder Capital, Johnson & Johnson Innovation – JJDC, Inc., and GT Healthcare Capital Partners
Series B (2024): $37M led by JCInvestco, Rex Health Ventures, and Orlando Health
Key Investors in GI Windows
Rex Health Ventures
Rex Health Ventures (RHV) is an innovative platform established by UNC REX Healthcare to support and invest in healthcare technologies and companies. As an early-stage investment fund, it aims to enhance patient care by providing strategic investments to emerging healthcare entrepreneurs across North Carolina and the U.S. The organization leverages expertise from the UNC REX and UNC Health Care network to foster groundbreaking advancements in health. Founded in 2012, RHV is committed to driving breakthrough innovations in the healthcare sector.
Orlando Health
Orlando Health is a comprehensive, not-for-profit healthcare organization headquartered in Orlando, Florida. Serving Central Florida and beyond, it operates 17 hospitals, including the Orlando Regional Medical Center, Arnold Palmer Hospital for Children, and South Lake Hospital, among others. Additionally, Orlando Health manages over 200 outpatient locations, including emergency rooms, medical pavilions, and physician practices .
GT Healthcare Capital Partners
GT Healthcare Capital Partners is a venture capital company. It specializes in healthcare investments around the globe. The company is based in Central, Hong Kong.
What's next for GI Windows?
The recent major strategic investment signifies a pivotal moment for GI Windows, likely enabling the company to accelerate product development, expand its market reach, and scale its operations. With a strong foundation in anastomoses technology and backed by significant capital, GI Windows is poised for further innovation and growth within the competitive medical device industry. Future endeavors may include clinical trials, regulatory approvals, and broader commercialization efforts to solidify its market position.
See full GI Windows company page
